DPP4 and type 1 diabetes mellitus: The analyzed studies investigated the effect of DPP-4 inhibitors (such as sitagliptin, saxagliptin, and vildagliptin) on glycemic control in children, adolescents, and adults with T1DM, using HbA1c, C-peptide, and TIR as the primary outcomes.